154 related articles for article (PubMed ID: 18261731)
1. The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.
Kearns AK; Bilbie CL; Clarkson PM; White CM; Sewright KA; O'Fallon KS; Gadarla M; Thompson PD
Atherosclerosis; 2008 Sep; 200(1):121-5. PubMed ID: 18261731
[TBL] [Abstract][Full Text] [Related]
2. Creatine supplementation does not alter the creatine kinase response to eccentric exercise in healthy adults on atorvastatin.
Taylor BA; Panza G; Ballard KD; White CM; Thompson PD
J Clin Lipidol; 2018; 12(5):1305-1312. PubMed ID: 29945780
[TBL] [Abstract][Full Text] [Related]
3. Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance.
Ballard KD; Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
Atherosclerosis; 2013 Sep; 230(1):121-4. PubMed ID: 23958263
[TBL] [Abstract][Full Text] [Related]
4. A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study.
Farsang C; Athyros V; Gaw A;
Curr Med Res Opin; 2007 Aug; 23(8):1945-56. PubMed ID: 17626713
[TBL] [Abstract][Full Text] [Related]
5. Effect of statins on skeletal muscle function.
Parker BA; Capizzi JA; Grimaldi AS; Clarkson PM; Cole SM; Keadle J; Chipkin S; Pescatello LS; Simpson K; White CM; Thompson PD
Circulation; 2013 Jan; 127(1):96-103. PubMed ID: 23183941
[TBL] [Abstract][Full Text] [Related]
6. The influence of atorvastatin on walking performance in peripheral arterial disease.
Bregar U; Poredos P; Sabovic M; Jug B; Sebestjen M
Vasa; 2009 May; 38(2):155-9. PubMed ID: 19588303
[TBL] [Abstract][Full Text] [Related]
7. Multiple-dose pharmacokinetics, pharmacodynamics, and safety of atorvastatin, an inhibitor of HMG-CoA reductase, in healthy subjects.
Cilla DD; Whitfield LR; Gibson DM; Sedman AJ; Posvar EL
Clin Pharmacol Ther; 1996 Dec; 60(6):687-95. PubMed ID: 8988072
[TBL] [Abstract][Full Text] [Related]
8. No adverse effects of statins on muscle function and health-related parameters in the elderly: an exercise study.
Panayiotou G; Paschalis V; Nikolaidis MG; Theodorou AA; Deli CK; Fotopoulou N; Fatouros IG; Koutedakis Y; Sampanis M; Jamurtas AZ
Scand J Med Sci Sports; 2013 Oct; 23(5):556-67. PubMed ID: 22288788
[TBL] [Abstract][Full Text] [Related]
9. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia.
Jayaram S; Prasad HB; Sovani VB; Langade DG; Mane PR
J Indian Med Assoc; 2007 Mar; 105(3):142-5, 150. PubMed ID: 17824470
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia.
Jones PH; McKenney JM; Karalis DG; Downey J
Am Heart J; 2005 Jan; 149(1):e1. PubMed ID: 15660024
[TBL] [Abstract][Full Text] [Related]
11. Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.
Chung J; Brass EP; Ulrich RG; Hiatt WR
Clin Pharmacol Ther; 2008 Feb; 83(2):243-50. PubMed ID: 17554242
[TBL] [Abstract][Full Text] [Related]
12. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
[TBL] [Abstract][Full Text] [Related]
13. Muscle tenderness and peak torque changes after downhill running following a prior bout of isokinetic eccentric exercise.
Eston RG; Finney S; Baker S; Baltzopoulos V
J Sports Sci; 1996 Aug; 14(4):291-9. PubMed ID: 8887208
[TBL] [Abstract][Full Text] [Related]
14. The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia.
Lam HC; Chu CH; Wei MC; Keng HM; Lu CC; Sun CC; Lee JK; Chuang MJ; Wang MC; Tai MH
Exp Biol Med (Maywood); 2006 Jun; 231(6):1010-5. PubMed ID: 16741040
[TBL] [Abstract][Full Text] [Related]
15. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
[TBL] [Abstract][Full Text] [Related]
16. Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
LaRosa JC; Grundy SM; Waters DD; Shear C; Barter P; Fruchart JC; Gotto AM; Greten H; Kastelein JJ; Shepherd J; Wenger NK;
N Engl J Med; 2005 Apr; 352(14):1425-35. PubMed ID: 15755765
[TBL] [Abstract][Full Text] [Related]
17. Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study.
Martineau P; Gaw A; de Teresa E; Farsang C; Gensini GF; Leiter LA; Langer A;
Atherosclerosis; 2007 Mar; 191(1):135-46. PubMed ID: 16643923
[TBL] [Abstract][Full Text] [Related]
18. Adding exercise training to rosuvastatin treatment: influence on serum lipids and biomarkers of muscle and liver damage.
Coen PM; Flynn MG; Markofski MM; Pence BD; Hannemann RE
Metabolism; 2009 Jul; 58(7):1030-8. PubMed ID: 19411087
[TBL] [Abstract][Full Text] [Related]
19. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
[TBL] [Abstract][Full Text] [Related]
20. A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.
Thompson PD; Parker BA; Clarkson PM; Pescatello LS; White CM; Grimaldi AS; Levine BD; Haller RG; Hoffman EP
Prev Cardiol; 2010; 13(3):104-11. PubMed ID: 20626664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]